Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v1-EN
Language French English
Date Updated 2019-05-29 2019-04-30
Drug Identification Number 00710814 00710814
Brand name EPINEPHRINE INJECTION USP EPINEPHRINE INJECTION USP
Common or Proper name Epinephrine Injection USP Epinephrine Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 0.1MG 0.1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRACARDIAC INTRAVENOUS INTRACARDIAC INTRAVENOUS
Packaging size 10 x 10mL LifeShield Syringe 10 x 10mL LifeShield Syringe
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-05-24
Actual start date 2019-04-30
Estimated end date 2019-06-21
Actual end date 2019-05-28
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Current inventory is on preventative allocation. Current inventory is on preventative allocation.
Health Canada comments